Want to join the conversation?
For 3Q16, $NKE's consolidated GM was flat, while it increased 40 BP for the first nine months of fiscal 2016. The company's 3Q16 effective tax rate was 810 BP lower than 3Q15 primarily due to an increase in the proportion of earnings from operations outside the US.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.